COMBINATION OF AN IL-1/18 INHIBITOR WITH A TNF INHIBITOR FOR THE TREATMENT OF INFLAMMATION

Details for Australian Patent Application No. 2002341321 (hide)

Owner PFIZER PRODUCTS INC.

Inventors GABEL, Christopher, Allen; DOMBROSKI, Mark, Anthony

Pub. Number AU-A-2002341321

PCT Number PCT/IB02/04367

PCT Pub. Number WO2003/045400

Priority 60/334,419 30.11.01 US

Filing date 18 October 2002

Wipo publication date 10 June 2003

International Classifications

A61K 031/64 - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/334,419 30.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002341321

19 August 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002341322-REMOTE RETRIEVAL OF CALLER ID INFORMATION AND INCOMING CALL LOGS

2002341320-SULFONYL-AND SULFONYLHETEROARYL-PYRAZOLES WITH A HYDRAZINYL OR NITROGEN OXIDE SUBSTITUENT AT THE 5-POSITION FOR USE AS CYCLOOXYGENASE INHIBITORS